BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25583770)

  • 1. Cost implications and complications of overtreatment of low-risk prostate cancer in the United States.
    Aizer AA; Gu X; Chen MH; Choueiri TK; Martin NE; Efstathiou JA; Hyatt AS; Graham PL; Trinh QD; Hu JC; Nguyen PL
    J Natl Compr Canc Netw; 2015 Jan; 13(1):61-8. PubMed ID: 25583770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
    Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
    JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer.
    Lao C; Edlin R; Rouse P; Brown C; Holmes M; Gilling P; Lawrenson R
    BMC Cancer; 2017 Aug; 17(1):529. PubMed ID: 28789623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of serious mental illness on the treatment and mortality of older patients with locoregional high-grade (nonmetastatic) prostate cancer: retrospective cohort analysis of 49 985 SEER-Medicare patients diagnosed between 2006 and 2013.
    Fried DA; Sadeghi-Nejad H; Gu D; Zhou S; He W; Giordano SH; Pentakota SR; Demissie K; Helmer D; Shen C
    Cancer Med; 2019 May; 8(5):2612-2622. PubMed ID: 30945473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States.
    Miller DC; Gruber SB; Hollenbeck BK; Montie JE; Wei JT
    J Natl Cancer Inst; 2006 Aug; 98(16):1134-41. PubMed ID: 16912266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States.
    Loeb S; Walter D; Curnyn C; Gold HT; Lepor H; Makarov DV
    J Urol; 2016 Sep; 196(3):721-6. PubMed ID: 26946161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate utilization of radiographic imaging in men with newly diagnosed prostate cancer in the United States.
    Prasad SM; Gu X; Lipsitz SR; Nguyen PL; Hu JC
    Cancer; 2012 Mar; 118(5):1260-7. PubMed ID: 21823112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act.
    Mahal BA; Aizer AA; Ziehr DR; Hyatt AS; Lago-Hernandez C; Chen YW; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Trinh QD; Nguyen PL
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):273-9. PubMed ID: 24980272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in treatment associated with life expectancy in a population-based cohort of men with early-stage prostate cancer.
    Daskivich TJ; Lai J; Dick AW; Setodji CM; Hanley JM; Litwin MS; Saigal C;
    Cancer; 2014 Dec; 120(23):3642-50. PubMed ID: 25042117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer trends in the era of prostate-specific antigen. An update of incidence, mortality, and clinical factors from the SEER database.
    Stephenson RA
    Urol Clin North Am; 2002 Feb; 29(1):173-81. PubMed ID: 12109343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urologist-Level Correlation in the Use of Observation for Low- and High-Risk Prostate Cancer.
    Tyson MD; Graves AJ; O'Neil B; Barocas DA; Chang SS; Penson DF; Resnick MJ
    JAMA Surg; 2017 Jan; 152(1):27-34. PubMed ID: 27653425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis.
    Liauw SL; Ham SA; Das LC; Rudra S; Packiam VT; Koshy M; Weichselbaum RR; Becker YT; Bodzin AS; Eggener SE
    J Natl Cancer Inst; 2020 Aug; 112(8):847-854. PubMed ID: 31728517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based assessment of determining predictors for quality of prostate cancer surveillance.
    Chamie K; Williams SB; Hershman DL; Wright JD; Nguyen PL; Hu JC
    Cancer; 2015 Dec; 121(23):4150-7. PubMed ID: 26307939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation.
    Feldman AS; Meyer CP; Sanchez A; Krasnova A; Reznor G; Menon M; Kibel AS; Choueiri TK; Lipsitz SR; Sun M; Trinh QD
    J Urol; 2017 Nov; 198(5):1061-1068. PubMed ID: 28552709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.
    Beebe-Dimmer JL; Ruterbusch JJ; Cooney KA; Bolton A; Schwartz K; Schwartz AG; Heath E
    Cancer Med; 2019 Jun; 8(6):3325-3335. PubMed ID: 31094098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trade-Off between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era.
    Shen X; Kumar P
    J Urol; 2016 May; 195(5):1397-1402. PubMed ID: 26656266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.
    Moschini M; Fossati N; Sood A; Lee JK; Sammon J; Sun M; Pucheril D; Dalela D; Montorsi F; Karnes RJ; Briganti A; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2018 Jan; 4(1):68-74. PubMed ID: 28753764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in incidence and 5-year mortality in men with newly diagnosed, metastatic prostate cancer-A population-based analysis of 2 national cohorts.
    Helgstrand JT; Røder MA; Klemann N; Toft BG; Lichtensztajn DY; Brooks JD; Brasso K; Vainer B; Iversen P
    Cancer; 2018 Jul; 124(14):2931-2938. PubMed ID: 29723398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resource Use in the Last Year of Life Among Patients Who Died With Versus of Prostate Cancer.
    Dinan MA; Li Y; Zhang Y; Stewart SB; Curtis LH; George DJ; Reed SD
    Clin Genitourin Cancer; 2016 Feb; 14(1):28-37.e2. PubMed ID: 26382223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men.
    de Carvalho TM; Heijnsdijk EA; de Koning HJ
    Int J Cancer; 2016 May; 138(10):2522-8. PubMed ID: 26695380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.